{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:40:01Z","timestamp":1749948001961,"version":"3.41.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The incidence of pediatric inflammatory bowel disease is increasing. tumor necrosis factor alpha inhibitors medicines improved the prognosis of affected subjects. Nonetheless, a proportion of patients do not respond or lose response to treatment. Newer biologics, like ustekinumab, have been approved for adults. The pediatric off-label use of these drugs is increasing, despite limited safety evidence. We report a case of disseminated mycobacterial infection (MI) presenting with reactive polyarthritis (Poncet\u2019s disease, PD) in a girl with Crohn\u2019s disease receiving various immunosuppressants, including ustekinumab.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case Report:<\/jats:title>\n            <jats:p>A 12-year-old girl with Crohn\u2019s disease was admitted for acute-onset migratory polyarthritis of large and small joints and opioid-resistant pain. She had recently received adalimumab and methotrexate and was currently under treatment with ustekinumab. She was vaccinated with Bacillus Calmette-Gu\u00e9rin and screened for tuberculosis before starting immunosuppressants. Interferon-gamma release assay, Mantoux test and chest computed tomography scan were negative. Disseminated MI with PD was diagnosed following positive cultures for <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic> complex in blood and intestinal biopsies (with negative in synovial fluid and gastric aspirate). Whole-exome sequencing did not identify any genetic susceptibility to MI. Antituberculosis treatment eradicated MI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Children with inflammatory bowel disease receiving combination immunosuppressive treatments including tumor necrosis factor alpha inhibitors and anti-IL-12\/23 agents are at higher risk for MI. Disseminated MI should be considered and ruled out in these patients when presenting with pulmonary, extrapulmonary or unusual clinical manifestations, like PD. The collection of multiple specimens (including intestinal biopsies) for mycobacterial culture is recommended when mycobacterial disease is suspected.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004277","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T22:00:56Z","timestamp":1708466456000},"page":"543-549","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Disseminated Mycobacterial Infection With Reactive Polyarthritis (Poncet\u2019s Disease) During Immune-suppressive Treatment Including Ustekinumab for Pediatric Crohn\u2019s Disease"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3941-9952","authenticated-orcid":false,"given":"Chiara","family":"Minotti","sequence":"first","affiliation":[{"name":"From the Division of Pediatric Infectious Diseases, Department of Women\u2019s and Children\u2019s Health, University of Padova, Padova, Italy"},{"name":"PhD Program in Clinical Research, Pediatric Research Center, University Children\u2019s Hospital Basel, Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Costenaro","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Infectious Diseases, Department of Women\u2019s and Children\u2019s Health, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Don\u00e0","sequence":"additional","affiliation":[{"name":"From the Division of Pediatric Infectious Diseases, Department of Women\u2019s and Children\u2019s Health, University of Padova, Padova, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Zuliani","sequence":"additional","affiliation":[{"name":"Pediatric Radiology, Department for Integrated Diagnostic Services"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Bosa","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, Digestive Endoscopy, Hepatology and Care of the Child with Liver Transplantation, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberta","family":"Leon","sequence":"additional","affiliation":[{"name":"Research & Innovation (R&I Genetics) Srl"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Perilongo","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, University of Padova"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Gaio","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, Digestive Endoscopy, Hepatology and Care of the Child with Liver Transplantation, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Martini","sequence":"additional","affiliation":[{"name":"Pediatric Rheumatology, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova, Padova, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"Cananzi","sequence":"additional","affiliation":[{"name":"Pediatric Gastroenterology, Digestive Endoscopy, Hepatology and Care of the Child with Liver Transplantation, Department of Women\u2019s and Children\u2019s Health, University Hospital of Padova"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","article-title":"ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease.","volume":"15","author":"Kucharzik","year":"2021","journal-title":"J Crohns Colitis"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","article-title":"Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis.","volume":"14","author":"Bonovas","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R3-20250614","first-page":"CD008794","article-title":"Adverse effects of biologics: a network meta-analysis and cochrane overview.","volume":"2011","author":"Singh","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/cid\/ciz1138","article-title":"Tuberculosis disease in children and adolescents on therapy with antitumor necrosis factor-\u0251 Agents: a collaborative, multicenter paediatric tuberculosis network European trials group (ptbnet) study.","volume":"71","author":"Noguera-Julian","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ecco-jcc\/jjw129","article-title":"Negative screening does not rule out the risk of tuberculosis in patients with inflammatory bowel disease undergoing anti-TNF treatment: a descriptive study on the GETAID cohort.","volume":"10","author":"Abitbol","year":"2016","journal-title":"J Crohns Colitis"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"340","DOI":"10.14309\/ajg.0000000000000527","article-title":"Risk of tuberculosis in patients with inflammatory bowel disease on infliximab or adalimumab is dependent on the local disease burden of tuberculosis: a systematic review and meta-analysis.","volume":"115","author":"Kedia","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/thoraxjnl-2016-209397","article-title":"Corticosteroids and infliximab impair the performance of interferon-\u03b3 release assays used for diagnosis of latent tuberculosis.","volume":"72","author":"Edwards","year":"2017","journal-title":"Thorax"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/apt.13445","article-title":"Systematic review: predicting and optimising response to anti-TNF therapy in Crohn\u2019s disease - algorithm for practical management.","volume":"43","author":"Ding","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1053\/j.gastro.2008.07.014","article-title":"A randomized trial of ustekinumab, a human interleukin-12\/23 monoclonal antibody, in patients with moderate-to-severe Crohn\u2019s disease.","volume":"135","author":"Sandborn","year":"2008","journal-title":"Gastroenterology"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.crohns.2014.06.005","article-title":"Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn\u2019s disease--the McGill experience.","volume":"8","author":"Kopylov","year":"2014","journal-title":"J Crohns Colitis"},{"key":"R11-20250614","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/apt.14834","article-title":"Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study.","volume":"48","author":"Rowan","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2334-13-78","article-title":"Severe strongyloidiasis: a systematic review of case reports.","volume":"13","author":"Buonfrate","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R13-20250614","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3390\/v13061024","article-title":"Chikungunya beyond the tropics: where and when do we expect disease transmission in Europe?.","volume":"13","author":"Tjaden","year":"2021","journal-title":"Viruses"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s43042-022-00358-x","article-title":"Mendelian susceptibility to mycobacterial disease: an overview.","volume":"24","author":"Errami","year":"2023","journal-title":"Egypt J Med Hum Genet"},{"key":"R15-20250614","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.cmi.2022.03.004","article-title":"Mendelian susceptibility to mycobacterial diseases: state of the art.","volume":"28","author":"Noma","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10875-022-01357-8","article-title":"Mendelian susceptibility to mycobacterial disease: retrospective clinical and genetic study in Mexico.","volume":"43","author":"Pe\u00f1afiel Vicu\u00f1a","year":"2023","journal-title":"J Clin Immunol"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"631298","DOI":"10.3389\/fimmu.2021.631298","article-title":"Clinical and molecular findings in mendelian susceptibility to mycobacterial diseases: experience from India.","volume":"12","author":"Taur","year":"2021","journal-title":"Front Immunol"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jmb.2010.07.046","article-title":"Structural basis for the dual recognition of IL-12 and IL-23 by ustekinumab.","volume":"402","author":"Luo","year":"2010","journal-title":"J Mol Biol"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jgh.15128","article-title":"Ustekinumab for children and adolescents with inflammatory bowel disease at a tertiary children\u2019s hospital in Japan.","volume":"36","author":"Takeuchi","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0000000000002362","article-title":"Real world experience with ustekinumab in children and young adults at a tertiary care pediatric inflammatory bowel disease center.","volume":"69","author":"Dayan","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R22-20250614","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ecco-jcc\/jjab089","article-title":"Ustekinumab in paediatric patients with moderately to severely active Crohn\u2019s disease: pharmacokinetics, safety, and efficacy results from UniStar, a phase 1 Study.","volume":"15","author":"Rosh","year":"2021","journal-title":"J Crohns Colitis"},{"key":"R23-20250614","doi-asserted-by":"crossref","first-page":"i681","DOI":"10.1093\/ecco-jcc\/jjac190.0683","article-title":"P553 Active tuberculosis and opportunistic infections: Pooled safety analysis of ustekinumab through up to 5 years across all approved indications.","volume":"17","author":"Ghosh","year":"2023","journal-title":"J Crohns Colitis"},{"key":"R24-20250614","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jaad.2019.12.033","article-title":"Ustekinumab does not increase tuberculosis risk: Results from a national database in South Korea.","volume":"82","author":"Cho","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"R25-20250614","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.coi.2007.07.004","article-title":"Interleukin-12 and tuberculosis: an old story revisited.","volume":"19","author":"Cooper","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"R26-20250614","doi-asserted-by":"crossref","first-page":"eabq5204","DOI":"10.1126\/sciimmunol.abq5204","article-title":"Human IL-23 is essential for IFN-\u03b3-dependent immunity to mycobacteria.","volume":"8","author":"Philippot","year":"2023","journal-title":"Sci Immunol"},{"key":"R27-20250614","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2133.2012.11162.x","article-title":"A case of latent tuberculosis reactivation in a patient treated with ustekinumab without concomitant isoniazid chemoprophylaxis in the PEARL trial.","volume":"168","author":"Tsai","year":"2013","journal-title":"Br J Dermatol"},{"key":"R28-20250614","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1684\/ejd.2014.2386","article-title":"Latent tuberculosis reactivation in a patient with erythrodermic psoriasis under treatment with ustekinumab and a low dose steroid, despite isoniazid chemoprophylaxis.","volume":"24","author":"Errichetti","year":"2014","journal-title":"Eur J Dermatology"},{"key":"R29-20250614","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jdcr.2017.02.001","article-title":"Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis.","volume":"3","author":"Lynch","year":"2017","journal-title":"JAAD case reports"},{"key":"R30-20250614","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.cgh.2021.02.025","article-title":"Five-year efficacy and safety of ustekinumab treatment in Crohn\u2019s disease: the IM-UNITI trial.","volume":"20","author":"Sandborn","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R31-20250614","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1365-2133.2012.11142.x","article-title":"The safety of ustekinumab treatment in patients with moderate-to-severe psoriasis and latent tuberculosis infection.","volume":"167","author":"Tsai","year":"2012","journal-title":"Br J Dermatol"},{"key":"R32-20250614","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archdermatol.2012.2958","article-title":"Peripheral lymph node recurrence of tuberculosis after ustekinumab treatment.","volume":"148","author":"S\u00e1nchez-Moya","year":"2012","journal-title":"Arch Dermatol"},{"key":"R33-20250614","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.arbres.2020.11.008","article-title":"A case of disseminated tuberculosis in a child with Crohn\u2019s disease after treatment with azathioprine, adalimumab and Ustekinumab.","volume":"57","author":"Renoux","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"R34-20250614","doi-asserted-by":"crossref","first-page":"e22897","DOI":"10.1097\/MD.0000000000022897","article-title":"Higher risk of tuberculosis in combination therapy for inflammatory bowel disease: a nationwide population-based cohort study in South Korea.","volume":"99","author":"Choi","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"R36-20250614","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R37-20250614","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2515\/therapie\/2013016","article-title":"Updating the French method for the causality assessment of adverse drug reactions.","volume":"68","author":"Arimone","year":"2013","journal-title":"Therapie"},{"key":"R38-20250614","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.clinre.2015.02.003","article-title":"Immune dysregulation in Alagille syndrome: a new feature of the evolving phenotype.","volume":"39","author":"Tilib Shamoun","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R39-20250614","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/20469047.2018.1467073","article-title":"Poncet\u2019s disease in an adolescent with abdominal tuberculosis.","volume":"39","author":"Shah","year":"2019","journal-title":"Paediatr Int Child Health"},{"key":"R40-20250614","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/1756-185X.12726","article-title":"A case series and review of Poncet\u2019s disease, and the utility of current diagnostic criteria.","volume":"19","author":"Sharma","year":"2016","journal-title":"Int J Rheum Dis"},{"key":"R41-20250614","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/tropej\/fmaa116","article-title":"Poncet\u2019s disease: a case report.","volume":"67","author":"Verma","year":"2021","journal-title":"J Trop Pediatr"},{"key":"R42-20250614","first-page":"1","article-title":"Poncet\u2019s disease in the preclinical phase of rheumatoid arthritis.","volume":"2018","author":"Nyo","journal-title":"Case Rep Rheumatol"},{"key":"R43-20250614","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10067-013-2270-y","article-title":"Clinical features of Poncet\u2019s disease. from the description of 198 cases found in the literature.","volume":"32","author":"Rueda","year":"2013","journal-title":"Clin Rheumatol"},{"key":"R44-20250614","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jpeds.2019.10.042","article-title":"Alagille syndrome and chronic arthritis: an international case series.","volume":"218","author":"Ferrara","year":"2020","journal-title":"J Pediatr"},{"key":"R45-20250614","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12876-022-02519-z","article-title":"Differential diagnosis of Crohn\u2019s disease and intestinal tuberculosis: development and assessment of a nomogram prediction model.","volume":"22","author":"Zeng","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"R47-20250614","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12879-017-2397-6","article-title":"Complications of miliary tuberculosis: low mortality and predictive biomarkers from a UK cohort.","volume":"17","author":"Underwood","year":"2017","journal-title":"BMC Infect Dis"},{"key":"R48-20250614","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00431-022-04640-3","article-title":"Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-\u03b1 inhibitor initiation in children in Spain.","volume":"182","author":"Calzada-Hern\u00e1ndez","year":"2023","journal-title":"Eur J Pediatr"},{"key":"R49-20250614","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/00006454-199111000-00008","article-title":"Miliary tuberculosis in children: a review of 94 cases.","volume":"10","author":"Hussey","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"R50-20250614","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/tid.12263","article-title":"Disseminated Bacillus Calmette-Gu\u00e9rin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with bare lymphocyte syndrome type II.","volume":"16","author":"Abu-Arja","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R51-20250614","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Gu\u00e9rin disease after vaccination: case report and review.","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R52-20250614","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10875-020-00892-6","article-title":"Bacillus Calmette-Guerin (BCG) vaccine-associated complications in immunodeficient patients following stem cell transplantation.","volume":"41","author":"NaserEddin","year":"2021","journal-title":"J Clin Immunol"},{"key":"R53-20250614","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.crohns.2010.05.001","article-title":"Case report: fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn\u2019s disease.","volume":"4","author":"Cheent","year":"2010","journal-title":"J Crohns Colitis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:02:19Z","timestamp":1749945739000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004277","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2024,2,20]]}}}